Progyny, Inc. Form 8-K Summary
Business Context and Reporting Period
Progyny, Inc. (PGNY), a Delaware corporation, filed this Current Report on Form 8-K on November 6, 2025. The filing announces the financial results for the fiscal quarter ended September 30, 2025. The company's principal executive offices are located in New York, New York.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release (Exhibit 99.1) and the supplemental earnings presentation (Exhibit 99.2), which are incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text provided. Investors must refer to the attached exhibits for comparative financial analysis.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are not detailed in the 8-K text itself. The filing notes that a supplemental earnings presentation is available on the company's investor relations website. The document includes standard disclaimers stating that the information furnished under Item 2.02 and Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures in the attached Press Release (Exhibit 99.1).
- Review the Third Quarter Earnings Supplemental Presentation (Exhibit 99.2) for detailed margin analysis and cash flow data.
- Confirm any updated financial guidance provided in the supplemental materials.
- Note that the 8-K text serves as a notification of the release rather than a source of granular financial data.